Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Re-thinking angina.

C R Conti1

  • 1University of Florida College of Medicine, 1600 SW Archer Road; Room M-438, Gainesville, FL 32610-0277, USA. conticr@medicine.ufl.edu

Clinical Cardiology
|February 1, 2007
PubMed
Summary
This summary is machine-generated.

Chronic stable angina, a condition affecting millions, involves myocardial ischemia due to oxygen supply-demand imbalance. Ranolazine offers a new therapeutic approach by targeting cellular ion disruptions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of mechanical valve thrombosis during pregnancy.

Clinical cardiology·2007
Same author

Inhibition of sodium-dependent calcium overload to treat myocardial ischemia.

Clinical cardiology·2006
Same author

How will INVEST and other hypertension trials change clinical practice?

Clinical cardiology·2001
Same author

Ibutilide: efficacy and safety in atrial fibrillation and atrial flutter in a general cardiology practice.

Clinical cardiology·2001
Same author

Updated pathophysiologic concepts in unstable coronary artery disease.

American heart journal·2001
Same author

Thrombolytic therapy for acute myocardial infarction: what dose should be used?

Clinical cardiology·2000
Same journal

In-Hospital Cardiac Arrest Detection Performance Analysis and Comparison on Effective Feature Selection.

Clinical cardiology·2026
Same journal

Heart Failure With Preserved Ejection Fraction-Like Phenotype in Coronary Artery Disease and Obstructive Sleep Apnea: Insights From the RICCADSA Cohort.

Clinical cardiology·2026
Same journal

Ethanol Infusion Into the Vein of Marshall for Atrial Fibrillation: Clinical Efficacy and Technical Limitations.

Clinical cardiology·2026
Same journal

Inpatient Outcomes and Complications After Left Atrial Appendage Occlusion in Rural Versus Urban Hospitals in the United States.

Clinical cardiology·2026
Same journal

Evaluate the Prognostic Value of serumγKlotho on Long-Term Prognosis of Patients With Multivessel Coronary Artery Disease and Establish a Prognostic Model.

Clinical cardiology·2026
Same journal

Trends and Disparities in Acute Myocardial Infarction-Related Mortality With Co-Listed Nicotine Dependence in the United States, 1999-2020.

Clinical cardiology·2026
See all related articles

Area of Science:

  • Cardiology
  • Molecular Cardiology

Background:

  • Angina pectoris, first described in 1772, remains a significant cardiovascular condition.
  • Chronic stable angina affects millions, with symptoms including chest discomfort, arrhythmias, and left ventricular dysfunction.

Observation:

  • Myocardial ischemia arises from an imbalance between oxygen supply and demand, often caused by coronary stenosis.
  • Cellular sodium and calcium homeostasis disruption contributes to myocardial ischemia, increasing intracellular sodium and calcium.
  • This ionic imbalance leads to electrical instability and mechanical dysfunction, exacerbating ischemia.

Findings:

  • Ranolazine selectively inhibits the late sodium current, a novel mechanism for anti-anginal therapy.
  • This action attenuates ventricular repolarization and contractility abnormalities linked to myocardial ischemia.

Related Experiment Videos

Implications:

  • Ranolazine represents the first new class of anti-anginal medication in 25 years.
  • It provides physicians with an additional therapeutic option for managing chronic stable angina.
  • This may improve patient outcomes alongside existing treatments like beta-blockers, calcium antagonists, and nitrates.